25
Participants
Start Date
March 1, 2023
Primary Completion Date
September 30, 2024
Study Completion Date
October 31, 2024
Maraciclatide
Imaging marker that binds to AVB3/5 lesions
John Radcliffe Hospital, Oxford
University of Oxford
OTHER